• new product

FluoRok raises £7.7m ($9.8m) to transform the safety and sustainability of fluorochemical production

PRNewswire September 23, 2024

OXFORD, England, Sept. 23, 2024 /PRNewswire/ — FluoRok, an Oxford-based start-up, has raised £7.7m to scale-up, manufacture and commercialise novel fluorochemical reagents and battery electrolyte salts. The oversubscribed round was led by BGF alongside Green Generation Fund and included battery specialist Volta Energy Technologies, current investors (Oxford Science Enterprises and University of Oxford), Excellis Holding and angels.

FluoRok team

Founded in 2022, FluoRok is a University of Oxford spin-out that has developed an innovative patented method to access fluorochemicals, chemicals containing the element fluorine and key to global energy transition, healthcare and food supply.

With a growing market valued at $24bn, fluorochemical manufacturing relies on a centuries-old, carbon-intensive process centred around hydrogen fluoride (HF), a highly-toxic, hazardous and difficult-to-handle chemical. FluoRok has developed a safe and sustainable approach completely bypassing HF and providing environmentally friendly access to fluorochemicals while reducing process costs. FluoRok’s groundbreaking innovation has gained substantial traction, attracting numerous potential customers across core markets of Li-ion battery electrolyte salts and agrochemicals.

The funding will support team growth and expanded production facilities for the initial supply of fluorinating reagents and lithium hexafluorophosphate (LiPF6), a key component of lithium-ion batteries.

Dr Gabriele Pupo, CEO and founder of FluoRok, said: “We are delighted to welcome BGF, Green Generation Fund and Volta Energy Technologies to our investor base. Their experience of building breakthrough businesses in battery and sustainable technologies is invaluable. With an outstanding investor syndicate, we continue our mission to make fluorochemicals production safer, cheaper, and more sustainable. This investment is critical in scaling and commercialising our proprietary technology with partners across the global fluorochemical supply chain, and in accelerating technology that will provide a reliable and localised supply of a key component of Li-ion batteries.”

Dennis Atkinson, investor at BGF, said: “FluoRok’s approach transforms the safety and sustainability of fluorochemical production while reducing costs. Particularly encouraging is significant early demand from customers worldwide and we look forward to supporting FluoRok’s journey to disrupt the global market and reach commercial scale.”

Manon Littek, founding partner at Green Generation Fund, said: “FluoRok’s revolutionary process offers a breakthrough for the fluorination industry, enabling access to compounds fundamental to energy transition, global food supply, and health. As we continue our mission toward a resilient and sustainable future, GGF is thrilled to partner with a future global leader in fluorination and supply chain independence.”

Dr Jeff Chamberlain, CEO and Founder of Volta Energy Technologies said: “Volta is enthused and eager to support FluoRok as it commercialises and scales its unique fluorinating agents. The use of FluoRok’s reagents in the battery industry promises to enable production of fluorinated electrolyte salts, like LiPF6, without the use of toxic and corrosive hydrofluoric acid. This will reduce barrier-to-entry to the electrolyte industry in Europe and North America. Beyond the battery industry, numerous applications for FluoRok reagents provide potential to have an impact in many global markets.”

Notes:
www.fluorok.com www.bgf.co.uk  www.greengenerationfund.com
www.volta.vc

Enquiries info@fluorok.com

FluoRok Logo

 

SOURCE FluoRok Limited

AAPR aggregates press releases and media statements from around the world to assist our news partners with identifying and creating timely and relevant news.

All of the press releases published on this website are third-party content and AAP was not involved in the creation of it. Read the full terms.